Dr Karl Robert Freydl, DO | |
29275 Northwestern Hwy, Ste 100, Southfield, MI 48034 | |
(877) 784-3667 | |
(248) 869-3982 |
Full Name | Dr Karl Robert Freydl |
---|---|
Gender | Male |
Speciality | Interventional Pain Management |
Experience | 26 Years |
Location | 29275 Northwestern Hwy, Southfield, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720183353 | NPI | - | NPPES |
5811183 | Other | MI | BCBS OF MI PIN |
2335426 | Other | MI | UNITED HEALTH CARE NO |
1720183353 | Other | MI | BCN |
50146067 | Other | MI | HAP |
140164 | Other | MI | CARE CHOICE INDIVIDUAL NO |
7876357 | Other | MI | AETNA INDIVIDUAL NO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | 5101015444 (Michigan) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Neurosurgical Associates Pc | 9739139759 | 38 |
News Archive
Drugs that promise to help people lose weight have had a checkered past, such as the infamous fen-phen that was pulled from the market in 1997 after reports of heart valve damage. But now, drug company pipelines are filling up with new molecules that aim to help people safely shed extra pounds, according to a cover story in Chemical & Engineering News, an independent news outlet of the American Chemical Society.
CCH has issued a special Briefing on the employer and Medicare- and Medicaid-related provisions in the House version of health care reform, detailing provisions of the legislation approved on November 7.
Texas Children's Hospital and SynCardia Systems, Inc. announced today that Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial Heart. The hospital intends to use the Total Artificial Heart as a bridge to transplant for their patients who received a heart transplant as children and now require mechanical support as a bridge to their second transplant.
Researchers at the Babraham Institute and University of Massachusetts Medical School in the United States have developed a new model to study motor neuron degeneration and have used this to identify three genes involved in the neurodegeneration process. These findings could have relevance for understanding the progression of amyotrophic lateral sclerosis (ALS) and other forms of motor neuron disease (MND).
High blood levels of the serum C-peptide are linked to heart disease and death in people without diabetes, according to a large study published in CMAJ.
› Verified 6 days ago
Entity Name | University Neurosurgical Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699761379 PECOS PAC ID: 9739139759 Enrollment ID: O20050127000624 |
News Archive
Drugs that promise to help people lose weight have had a checkered past, such as the infamous fen-phen that was pulled from the market in 1997 after reports of heart valve damage. But now, drug company pipelines are filling up with new molecules that aim to help people safely shed extra pounds, according to a cover story in Chemical & Engineering News, an independent news outlet of the American Chemical Society.
CCH has issued a special Briefing on the employer and Medicare- and Medicaid-related provisions in the House version of health care reform, detailing provisions of the legislation approved on November 7.
Texas Children's Hospital and SynCardia Systems, Inc. announced today that Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial Heart. The hospital intends to use the Total Artificial Heart as a bridge to transplant for their patients who received a heart transplant as children and now require mechanical support as a bridge to their second transplant.
Researchers at the Babraham Institute and University of Massachusetts Medical School in the United States have developed a new model to study motor neuron degeneration and have used this to identify three genes involved in the neurodegeneration process. These findings could have relevance for understanding the progression of amyotrophic lateral sclerosis (ALS) and other forms of motor neuron disease (MND).
High blood levels of the serum C-peptide are linked to heart disease and death in people without diabetes, according to a large study published in CMAJ.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Karl Robert Freydl, DO 46325 W 12 Mile Rd., Ste. 100, Novi, MI 48377 Ph: (877) 784-3667 | Dr Karl Robert Freydl, DO 29275 Northwestern Hwy, Ste 100, Southfield, MI 48034 Ph: (877) 784-3667 |
News Archive
Drugs that promise to help people lose weight have had a checkered past, such as the infamous fen-phen that was pulled from the market in 1997 after reports of heart valve damage. But now, drug company pipelines are filling up with new molecules that aim to help people safely shed extra pounds, according to a cover story in Chemical & Engineering News, an independent news outlet of the American Chemical Society.
CCH has issued a special Briefing on the employer and Medicare- and Medicaid-related provisions in the House version of health care reform, detailing provisions of the legislation approved on November 7.
Texas Children's Hospital and SynCardia Systems, Inc. announced today that Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial Heart. The hospital intends to use the Total Artificial Heart as a bridge to transplant for their patients who received a heart transplant as children and now require mechanical support as a bridge to their second transplant.
Researchers at the Babraham Institute and University of Massachusetts Medical School in the United States have developed a new model to study motor neuron degeneration and have used this to identify three genes involved in the neurodegeneration process. These findings could have relevance for understanding the progression of amyotrophic lateral sclerosis (ALS) and other forms of motor neuron disease (MND).
High blood levels of the serum C-peptide are linked to heart disease and death in people without diabetes, according to a large study published in CMAJ.
› Verified 6 days ago
Dr. Joel R Schechet, MD Pain Medicine Medicare: Medicare Enrolled Practice Location: 26025 Lahser, 2nd Floor, Southfield, MI 48033 Phone: 248-663-1900 Fax: 248-663-1902 | |
Dr. Nazih Iskander, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 18161 W 13 Mile Rd, Ste C, Southfield, MI 48076 Phone: 216-401-9257 | |
Dr. Daniel A. Schwarz, MD Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 18444 W 10 Mile Rd, Suite 102, Southfield, MI 48075 Phone: 248-798-0368 Fax: 888-330-7328 |